INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 213 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,262 | -99.6% | 68,068 | +810.6% | 0.01% | +150.0% |
| Q2 2020 | $358,000 | -21.3% | 7,475 | +3.4% | 0.00% | -50.0% |
| Q1 2020 | $455,000 | -45.0% | 7,232 | +8.3% | 0.00% | -20.0% |
| Q4 2019 | $827,000 | +64.7% | 6,677 | -11.8% | 0.01% | +25.0% |
| Q3 2019 | $502,000 | -19.7% | 7,567 | -3.7% | 0.00% | -20.0% |
| Q2 2019 | $625,000 | -37.5% | 7,857 | -12.1% | 0.01% | -37.5% |
| Q1 2019 | $1,000,000 | +17.2% | 8,937 | +5.6% | 0.01% | 0.0% |
| Q4 2018 | $853,000 | -22.1% | 8,462 | -2.4% | 0.01% | -11.1% |
| Q3 2018 | $1,095,000 | +54.9% | 8,667 | +2.9% | 0.01% | +28.6% |
| Q2 2018 | $707,000 | +61.0% | 8,422 | +18.0% | 0.01% | +75.0% |
| Q1 2018 | $439,000 | +16.8% | 7,137 | +10.9% | 0.00% | 0.0% |
| Q4 2017 | $376,000 | +84.3% | 6,437 | +83.4% | 0.00% | +100.0% |
| Q3 2017 | $204,000 | -51.0% | 3,509 | +2.2% | 0.00% | -60.0% |
| Q2 2017 | $416,000 | +9.2% | 3,435 | +1.8% | 0.01% | 0.0% |
| Q1 2017 | $381,000 | +1.3% | 3,373 | -2.5% | 0.01% | -16.7% |
| Q4 2016 | $376,000 | -37.4% | 3,460 | -5.2% | 0.01% | -45.5% |
| Q3 2016 | $601,000 | +26.5% | 3,650 | -1.3% | 0.01% | -8.3% |
| Q1 2016 | $475,000 | -1.7% | 3,698 | +14.5% | 0.01% | 0.0% |
| Q4 2015 | $483,000 | -19.6% | 3,231 | -10.8% | 0.01% | -29.4% |
| Q3 2015 | $601,000 | -99.9% | 3,621 | +12.1% | 0.02% | +6.2% |
| Q2 2015 | $779,657,000 | +113884.9% | 3,230 | +33.2% | 0.02% | +23.1% |
| Q1 2015 | $684,000 | -99.7% | 2,425 | +47.9% | 0.01% | +160.0% |
| Q4 2014 | $255,840,000 | -58.4% | 1,640 | -36.9% | 0.01% | -61.5% |
| Q3 2014 | $615,394,000 | +147.7% | 2,600 | +147.6% | 0.01% | +160.0% |
| Q2 2014 | $248,462,000 | – | 1,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $39,083,000 | 9.04% |
| Senvest Management, LLC | 1,152,032 | $70,873,000 | 5.40% |
| Melqart Asset Management (UK) Ltd | 298,200 | $18,345,000 | 2.20% |
| Elk Creek Partners, LLC | 348,454 | $21,437,000 | 1.25% |
| ALTRINSIC GLOBAL ADVISORS LLC | 375,223 | $23,084,000 | 0.93% |
| BB BIOTECH AG | 545,719 | $33,573,000 | 0.93% |
| Virtus ETF Advisers LLC | 14,681 | $903,000 | 0.78% |
| Opus Point Partners Management, LLC | 4,496 | $277,000 | 0.54% |
| Spark Investment Management LLC | 136,500 | $8,397,000 | 0.54% |
| Regal Investment Advisors LLC | 29,511 | $1,816,000 | 0.40% |